Arrien Pharmaceuticals

Arrien Pharmaceuticals is a clinical-stage drug discovery company dedicated to developing small molecules targeting protein kinase signaling, nuclear hormone receptors, and immuno-oncology/checkpoint pathway targets for the treatment of human cancers, autoimmune, and neurodegenerative diseases.